Literature DB >> 3040234

Characterization of a human osteosarcoma cell line (Saos-2) with osteoblastic properties.

S B Rodan, Y Imai, M A Thiede, G Wesolowski, D Thompson, Z Bar-Shavit, S Shull, K Mann, G A Rodan.   

Abstract

This study examines the osteoblastic properties of the established human osteosarcoma cell line Saos-2. Saos-2 cells inoculated into diffusion chambers, which were implanted i.p. into nude mice, produced mineralized matrix in 4 of 6 chambers at 8 weeks. In 5 of 6 chambers there was a strong positive alkaline phosphatase reaction. In culture the alkaline phosphatase levels increased with time and cell density, reaching very high levels at confluence: 4-7 mumol/mg protein/min. The cells show a sensitive adenylate cyclase response to parathyroid hormone, 50% effective dose = 2.8 nM, which increases with cell density and is further raised by dexamethasone treatment. They also exhibit typical binding of 1-25-dihydroxyvitamin D3 to 3.2S receptor protein with an apparent Kd of 0.21 nM; the numbers of sites per cell were 3,300 at 50,000 cells/cm2 and 1,800 at 280,000 cells/cm2. The presence of osteonectin was visualized with a monoclonal antibody which revealed a reticular pattern on the cell surface. Osteonectin was also detected in the medium by Western blots, migrating at around Mr 40,000 in nonreduced gels and Mr 44,000 in reduced gels. The Saos-2 cells thus possess several osteoblastic features and could be useful as a permanent line of human osteoblast-like cells and as a source of bone-related molecules.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3040234

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  124 in total

1.  In vitro expression of proalpha1(I) collagen mRNA by human pre-osteoclastic cells.

Authors:  L Masi; C Malentacchi; S Benvenuti; A Amedei; U Bigozzi; E Montali; M L Brandi
Journal:  J Endocrinol Invest       Date:  2000-01       Impact factor: 4.256

2.  Adhesion, growth, and matrix production by osteoblasts on collagen substrata.

Authors:  L Masi; A Franchi; M Santucci; D Danielli; L Arganini; V Giannone; L Formigli; S Benvenuti; A Tanini; F Beghè
Journal:  Calcif Tissue Int       Date:  1992-09       Impact factor: 4.333

3.  Effects of an Er:YAG laser on mitochondrial activity of human osteosarcoma-derived osteoblasts in vitro.

Authors:  Frank Schwarz; Daniel Rothamel; Monika Herten; Katrin Bieling; Werner Scherbaum; Jürgen Becker
Journal:  Lasers Med Sci       Date:  2004-07-08       Impact factor: 3.161

4.  Evaluation of the effect of three calcium phosphate powders on osteoblast cells.

Authors:  V Midy; M Dard; E Hollande
Journal:  J Mater Sci Mater Med       Date:  2001-03       Impact factor: 3.896

5.  Osteoblast-like cell response to calcium phosphate coating chemistry and morphology on etched silicon surfaces.

Authors:  George A Burke; Chris J Rea; Fergal G Horgan; Marie Turkington; Adrian R Boyd; Brian J Meenan
Journal:  J Mater Sci Mater Med       Date:  2012-03       Impact factor: 3.896

6.  Osteoblast-like cellular response to dynamic changes in the ionic extracellular environment produced by calcium-deficient hydroxyapatite.

Authors:  J Gustavsson; M P Ginebra; J Planell; E Engel
Journal:  J Mater Sci Mater Med       Date:  2012-06-24       Impact factor: 3.896

7.  Adaptive response of osteoblasts grown on a titanium surface: morphology, cell proliferation and stress protein synthesis.

Authors:  P Borghetti; E De Angelis; G Caldara; A Corradi; A Cacchioli; C Gabbi
Journal:  Vet Res Commun       Date:  2005-08       Impact factor: 2.459

8.  Prostaglandin-induced changes in calcium uptake and cAMP production in osteoblast-like cells: role of protein kinase C.

Authors:  S Hagel-Bradway; D N Tatakis; R Dziak
Journal:  Calcif Tissue Int       Date:  1991-04       Impact factor: 4.333

9.  Bone formation in vitro and in nude mice by human osteosarcoma cells.

Authors:  A Ogose; T Motoyama; T Hotta; H Watanabe; H E Takahashi
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

10.  Zoledronic acid up-regulates bone sialoprotein expression in osteoblastic cells through Rho GTPase inhibition.

Authors:  Michaël Chaplet; Cédric Detry; Christophe Deroanne; Larry W Fisher; Vincent Castronovo; Akeila Bellahcéne
Journal:  Biochem J       Date:  2004-12-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.